NephrosNEPH
Fair Value
US$6
Share price16 Dec
US$3.5540.8% undervalued intrinsic discount
1Y-12.99%
7D-0.84%
Hospital Infection Control Challenges May Limit Near-Term Upside Yet Long-Term Potential Appears Intact
AN
Analyst Low Target compiles bearish analysts opinions to create narratives which represent one standard deviation below the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls.
Published
16 Dec 25
Views
17
Not Invested